Influenza Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028
Influenza is a viral infection of the respiratory system and is majorly responsible for seasonal flu epidemics each year. Influenza is usually characterized by symptoms such as muscle aches, runny nose, headache, cough, congestion, fever, and fatigue. There are four types of influenza viruses which include type A, B, C, and D. The type influenza A and influenza B are usually referred to as human influenza viruses. Type A viruses are further segregated into two subtypes based on the differences in their viral surface proteins called hemagglutinin (H) and neuraminidase (N).
The global influenza vaccine market features a fragmented landscape owing to the strong presence of several key players in the market. These leading companies in the global market are constantly focusing on manufacturing technologically advanced products that will enhance efficiency. Naturally, the competition on the basis of pricing in the market quite high and is working in favor of the development of the global market. The existing market players are deploying various strategies and advanced techniques to thrive in the global market.
Some of the leading companies in the global influenza vaccine market include names such as Sinovac Biotech Ltd, Sanofi Pasteur SA, Novartis AG, Pfizer, Inc., Merck & Co., Inc. (Merck Sharp & Dohme Corp.), GlaxoSmithKline Plc., Gamma Vaccines Pty Ltd., Emergent BioSolutions, F. Hoffmann-La Roche Ltd, CSL Limited, Biodiem, and AstraZeneca Plc. among others.
Influenza is a contagious infection and is transmissible through the sneezing and coughing of an infected person. Vaccination serves as an effective method for the prevention of influenza which is propelling the demand of the global influenza vaccine market. Additionally, the availability of several influenza vaccines that have been prequalified by the WHO for purchase by the UN Agencies is boosting the advancement of the global market. Factors such as the development of new vaccines, advancements in existing vaccines, minimal side effects, funding and investments by companies in R&D activities, and a rise in the government initiatives to ensure well-being of population are also contributing to the growth of this market. An increase in routine immunization programs in the developed, as well as developing countries, is anticipated to drive the global influenza vaccine market towards progressive and lucrative opportunities.
The global influenza vaccine market has five main regions that provide the reader with the intricate details of the working dynamics of the regional landscape. These regions are North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Of these, currently, the global automated fare collection system market is growing remarkably owing to the substantial contribution of the regional segment of North America. Several factors such as the focus of the government on immunization programs, advancements in vaccine administration, the emergence of new vaccines, and the prevalence of influenza in the region are boosting the development of the global influenza vaccine market.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report